Pharma Mar SA (PHMMF)
Pharma Mar Market Cap : 1.848B for June 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Oryzon Genomics SA | 286.80M |
| Grifols SA | 1.899B |
| ACADIA Pharmaceuticals, Inc. | 3.665B |
| Alkermes Plc | 7.343B |
| Alnylam Pharmaceuticals, Inc. | 39.07B |
Market Cap Related Metrics
| PE Ratio | 20.04 |
| PS Ratio | 7.119 |
| PEG Ratio | 0.0595 |
| Price to Book Value | 6.426 |
| Price to Free Cash Flow | 26.58 |
| Price | 106.48 |
| Earnings Yield | 4.99% |
| PEGY Ratio | 0.0593 |
| Operating PE Ratio | 37.19 |
| Normalized PE Ratio | 20.04 |